Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-043270
Filing Date
2022-07-27
Accepted
2022-07-27 16:52:14
Documents
2
Period of Report
2022-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1589
2 EX-24 DOCUMENT attachment1.htm EX-24 4488
  Complete submission text file 0001209191-22-043270.txt   7446
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Kathiresan Sekar (Reporting) CIK: 0001864112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39385 | Film No.: 221111630